Perspective Therapeutics (CATX) Shares Outstanding (2011 - 2026)

Perspective Therapeutics' Shares Outstanding history runs 16 years deep, the most recent figure standing at $114.0 million for Q1 2026.

• In Q1 2026, Shares Outstanding rose 53.97% year-over-year to $114.0 million; the TTM figure through Mar 2026 stood at $114.0 million (up 53.97% YoY), while the FY2025 annual figure was $74.3 million, up 5.19% from the prior year.
• Shares Outstanding came in at $114.0 million for Q1 2026 at Perspective Therapeutics, up from $74.3 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $142.1 million in Q3 2022 to a low of $14.2 million in Q4 2022.
• A 5-year average of $72.2 million and a median of $70.7 million in 2024 frame the typical range for Shares Outstanding.
• Across the five-year window, Shares Outstanding plunged 89.99% in 2022 and soared 150.78% in 2024, its largest moves.
• Perspective Therapeutics' Shares Outstanding stood at $14.2 million in 2022, then jumped by 98.3% to $28.2 million in 2023, then jumped by 150.78% to $70.7 million in 2024, then increased by 5.19% to $74.3 million in 2025, then soared by 53.38% to $114.0 million in 2026.
• According to Business Quant data, Shares Outstanding over the past three periods registered $114.0 million, $74.3 million, and $74.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison